Table II.
Effect | Hazard ratio | 95% Wald confidence limits | P valueb | |
---|---|---|---|---|
Cr level ≥3 mg/dL | 5.9 | 2.1 | 16 | .0006 |
GFR <30 mL/min/1.73 m2 | 3.2 | 1.6 | 6.3 | .0011 |
Symptomatic | 1.3 | 0.8 | 1.9 | .2767 |
Hypertension | 1.4 | 0.8 | 2.5 | .2718 |
Renal insufficiency | 2.3 | 1.4 | 3.7 | .0005 |
Stroke | 1.6 | 0.95 | 2.6 | .077 |
Diabetes mellitus | 1.5 | 1.0 | 2.3 | .0382 |
Coronary artery disease | 1.3 | 0.8 | 1.9 | .2783 |
Hypercholesterolemia | 0.8 | 0.6 | 1.3 | .4368 |
Chronic obstructive pulmonary disease | 1.2 | 0.7 | 1.9 | .5068 |
Morbid obesity | 1.0 | 0.2 | 4.1 | .9959 |
Smoker | 0.9 | 0.6 | 1.3 | .5321 |
Cr, Creatine; GFR, glomerular filtration rate.
Cr level, 867 patients; GFR, 854 patients.
Boldface entries indicate statistical significance.